Search Results 471-480 of 16842 for Antagonist

  1. Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction - Mayo Clinic

    ... antagonists; No change in dosage of ACE, ARBs, beta-blockers,CCBs or aldosterone antagonists of more than 100%. One of the following within the last 12 months.

  2. A Study Comparing Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    Patients may not have received warfarin or another vitamin K antagonist in the preceding 30 days. Women must not be pregnant or breast-feeding since this ...

  3. A Phase 3 Efficacy and Safety Study of Pitolisant in Patients with Prader-Willi Syndrome - Mayo Clinic

    Is receiving a concomitant medication that is known to be a centrally acting H1R antagonist; patients who complete a washout for at least 5 half-lives prior to ...

  4. A Study of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease - Mayo Clinic

    ... antagonist or vedolizumab or ustekinumab, or having documented intolerance. Women of childbearing potential (WCBP) must have negative serum pregnancy test ...

  5. A Study to Evaluate the Effects of Losartan to Reduce Inflammation and Fibrosis Endpoints in Patients with HIV - Mayo Clinic

    ... antagonist); Current treatment with immunomodulatory drugs within the past 6 months; Current hepatitis treatments (e.g., interferon, ribavirin) within the ...

  6. Migraine - Diagnosis and treatment - Mayo Clinic

    Pain relievers. · Triptans. · Dihydroergotamine (Migranal, Trudhesa). · Lasmiditan (Reyvow). · Oral calcitonin gene-related peptides antagonists, also known as ...

  7. Hematology - Clinical trials

    Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...

  8. ABSORB III Randomized Controlled Trial (RCT) - Mayo Clinic

    Any surgery requiring general anesthesia or discontinuation of aspirin and/or an adenosine diphosphate (ADP) antagonist is planned within 12 months after the ...

  9. A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome - Mayo Clinic

    ... antagonist properties, including serotonin re-uptake inhibition; triptans, atomoxetine, or other centrally-acting noradrenergic agonist; cyproheptadine, and ...

  10. Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma (FLASH) - Mayo Clinic

    * Previous hepatotoxicity related to zileuton or leukotriene receptor antagonist (LTRAs) (eg montelukast). * Participants with a recent history of, or who ...